fbpx

11:05 – 12:00

Classification of triple negative breast cancer (TNBC) by DNA Damage Immune Response (DDIR) signature and Homologous Recombination Deficiency (HRD) status: Analysis of SWOG S9313 adjuvant trial

GS3-05

Social Share

× How can I help you?